Replies to post #67407 on Ayala Pharmaceuticals Inc (ADXS)

[blueyedcatch]

That`s the point,they diluted to sweat out a fair offer,because what was probably being offered after Dan`s low bar set was rejected. Just my opinion,but I talked feverishly about this situation way before hand with Noelle,and I believe we`ll get 200-300 million upfront before the years out,maybe by Sept, or Oct. Gotta make these sharks sweat,and we have quite a few circling our table.

[ignatiusrielly35]

That was Bourbon’s editorializing of Lombardo’s comments at the ASM. If he actually said or even implied that AXAL is old and of little value I will eat my flip flop. No chance a CEO says that at an annual meeting, even if it was true.

[Bourbon_on_my_cornflakes]

" Lombardo made a comment at the annual meeting implying AXAL was getting old, which reiterates O'Connors flawed strategy of holding out to get more. Now we're getting less be cause O'Connor did strike when the iron was hot early on"

There is no better summation of the entire flawed ADXS strategy and the mistaken assumptions of the uberlongs here who think AXAL is worth $200-300 million up front.

Crazy-eyed blue sky dreams for a product which may be getting left behind as the march of immunotherapy proceeds. That is what wrecked ADXS.

Think of all the time wasted on the SPA, yet no filing for accelerated approval. WWT?

People here are dreaming of $200-300m up front, I think Ken will be very lucky if he can get $50m up front, and $100 would be a grand slam.

So where is the $400m going to come to keep the doors open for the next 5 years? Either redoing/accelerating NEO, or doing a big one party deal for HOT.

Or by diluting ADXS stock down to the value of toilet paper.

If the latter happens, expect the company to be sold for less than $100 million eventually.

There is still a great arguement for selling the Comapny for $1-2 billion NOW, while the BP are repatriating their foreign profits and in an acquisitive mood.

sometimes waiting to sell get you LESS, not MORE